# Dyne Therapeutics, Inc.: Form 8-K, filed Sep 3, 2024

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: 8-K
- Filed: 2024-09-03
- Accepted by EDGAR: Sep 3, 2024, 07:16 ET
- Period: 2024-08-31
- Accession: 0001193125-24-211534
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000119312524211534/d786894d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000119312524211534/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000119312524211534/d786894d8k.htm

Filed Sep 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-211534. Last ingested by Listed: Nov 5, 2026, 12:06 ET. No prices; not investment advice.